Showing results (71-80 of 137) with videos related to
Sort By:
Pageof 14
Plos Pathogens|November 6, 2015
Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T CellsDerek D Sloan, Chia-Ying Kao Lam, Alivelu Irrinki, et al.Journal of Medicinal Chemistry|September 3, 2010
Synthesis of ester prodrugs of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agentsMarcela Krecmerová, Antoín Holý, Graciela Andrei, et al.Organic Letters|January 7, 2015
Abyssomicin 2 reactivates latent HIV-1 by a PKC- and HDAC-independent mechanismBrian León, Gabriel Navarro, Bailey J Dickey, et al.Science Translational Medicine|May 31, 2019
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challengeMichael K Lo, Friederike Feldmann, Joy M Gary, et al.Molecules (Basel, Switzerland)|July 9, 2022
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2Joy Y Feng, Venice Du Pont, Darius Babusis, et al.Journal of Natural Products|February 6, 2014
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cellsEric J Mejia, Steven T Loveridge, George Stepan, et al.Antimicrobial Agents and Chemotherapy|June 10, 2015
Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV InfectionRobert Jordan, Matt Shao, Richard L Mackman, et al.Journal of Virology|February 1, 2019
Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus ControlChristopher W Pohlmeyer, Veronica D Gonzalez, Alivelu Irrinki, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonatesRichard L Mackman, Constantine G Boojamra, Vidya Prasad, et al.Cell Reports|July 21, 2021
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.Pageof 14